IntegerBio: Clinical Trials

1 trial sponsored by IntegerBio, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow IntegerBio: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
IB-001, Placebo, Peginterferon Alfa-2A - Chronic Hepatitis B Virus Infection
Phase 1RecruitingIntegerBio882026-02-202026-09-28

Conditions studied

Hepatitis B (1)  ·  Hepatitis B, Chronic (1)

Interventions

peginterferon alfa-2a (1)

Countries

Hong Kong (1)  ·  Moldova (1)  ·  New Zealand (1)  ·  Ukraine (1)

Top investigators

Edward Gane, MBChB, MD, FRACP, MNZ (1)